InvestorsHub Logo
Followers 2
Posts 34
Boards Moderated 0
Alias Born 10/09/2020

Re: bidmark post# 318317

Wednesday, 01/06/2021 4:27:36 PM

Wednesday, January 06, 2021 4:27:36 PM

Post# of 426557
You're missing the point. The average patient isn't going to pay $200+ for Vascepa. Most Vascepa scripts written after Reduce-It were off-label. Prior Auths are cutting off coverage for people who got scripts that way.

Not only does BCBS-TX have prior auth, but they've installed age limits on coverage as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News